[Angiogenesis induced with neotype amphiphic peptide].

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Peptide Chemistry

Context:

• Angiogenesis, the formation of new blood vessels, is crucial for tissue repair and regeneration.
• Peptide-based biomaterials offer promising platforms for therapeutic applications due to their biocompatibility and tunable properties.
• The Isoleucine-Lysine-Valine-Alanine-Valine (IKVAV) peptide sequence is known for its bioactive properties.

Purpose:

• To investigate the in vivo angiogenesis-inducing capability of a self-assembled hydrogel formed from a neotype amphiphilic peptide containing the Isoleucine-Lysine-Valine-Alanine-Valine (IKVAV) sequence.
• To evaluate the biocompatibility and local tissue response to the peptide hydrogel.
• To assess the expression of vascular endothelial growth factor (VEGF) as a marker of angiogenesis.

Summary:

• The IKVAV-containing peptide self-assembled into a nanofibrous hydrogel, confirmed by transmission electron microscopy (TEM).
• Subcutaneous injection of the peptide hydrogel in rats showed no local inflammatory reactions or necrosis.
• Histological examination revealed significant capillary vessel formation and the presence of erythrocytes within the hydrogel, alongside increased VEGF expression in the experimental group compared to the gelatin control group.

Impact:

• The study demonstrates that the self-assembled IKVAV peptide hydrogel can effectively induce angiogenesis in vivo.
• This finding suggests the potential of IKVAV-based hydrogels as therapeutic agents for promoting tissue regeneration and treating ischemic diseases.
• Further research into optimizing the hydrogel formulation and delivery could lead to clinical applications in wound healing and tissue engineering.